David J. Cohen

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

Richard S. Finn, Judy Dering, Dylan Conklin et al. · Breast Cancer Research · 2009 · 1.4K citations · Full text

Additively manufactured 3D porous Ti-6Al-4V constructs mimic trabecular bone structure and regulate osteoblast proliferation, differentiation and local factor production in a porosity and surface roughness dependent manner

Alice Cheng, Aiza Humayun, David J. Cohen et al. · Biofabrication · 2014 · 256 citations · Full text

Tissue Engineering, Osteoblast Proliferation, Engineering +16

Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

Amy S. Paller, Eric L. Simpson, Elaine C. Siegfried et al. · The Lancet · 2022 · 242 citations · Full text

Asthma, Uncontrolled Atopic Dermatitis, Atopic Dermatitis +4

Acute mastoiditis — the antibiotic era: a multicenter study

Michał Luntz, Alexander Brodsky, S. Nusem et al. · International Journal of Pediatric Otorhinolaryngology · 2001 · 216 citations

Acute Mastoiditis, Antimicrobial Stewardship, Antibiotics +5

Dacomitinib (PF-00299804), an Irreversible Pan-HER Inhibitor, Inhibits Proliferation of HER2-Amplified Breast Cancer Cell Lines Resistant to Trastuzumab and Lapatinib

Ondrej Kalous, Dylan Conklin, Amrita Desai et al. · Molecular Cancer Therapeutics · 2012 · 84 citations · Full text

Human Egf, Breast Oncology, Oncology +14